Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2010
06/10/2010WO2010004054A3 Nucleic acid comprising zwitterionic nucleotides
06/10/2010WO2009104051A3 Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
06/10/2010US20100146672 Compositions and methods for increasing cellulose production
06/10/2010US20100146670 Methods and compositions for altering plant biomass
06/10/2010US20100146655 Methods and materials for producing transgenic animals
06/10/2010US20100146652 Xenobiotic related induction of gene expression
06/10/2010US20100146651 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
06/10/2010US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145626 Systems for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
06/10/2010US20100145039 siRNA targeting nucleoporin 62kDa (Nup62)
06/10/2010US20100145038 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
06/10/2010US20100145037 Dna amplification and sequencing using dna molecules generated by random fragmentation
06/10/2010US20100145030 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100145023 Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins
06/10/2010US20100144851 RNA Interference Mediated Inhibition of Platelet-Derived Endothelial Cell Growth Factor (ECGF1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/10/2010US20100144850 Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis
06/10/2010US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
06/10/2010US20100144848 Dna controlled assembly of lipid membranes
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144845 Oligonucleotide systems for targeted intracellular delivery
06/10/2010US20100144843 Rnai therapeutic for respiratory virus infection
06/10/2010US20100144842 RNA Interference Mediated Inhibition of NOGO and NOGO Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144836 Methods for Detecting Epigenetic Modifications
06/10/2010US20100144835 Inhibition of gpr4
06/10/2010US20100144834 Methods for treating hypercholesterolemia
06/10/2010US20100144833 RNA interference; respiratory syncytial virus (RSV), parainfluenza virus (PIV); down-regulation of a gene(s) of a respiratory virus by oligonucleotides via RNA interference which are administered locally to the lungs and nasal passage via inhalation/intranasally or systemically via injection/intravenous
06/10/2010US20100144832 Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
06/10/2010US20100144831 Blocking of gene expression in eukaryotic cells
06/10/2010US20100144830 Cancer cell identification marker and cancer cell proliferation inhibitor
06/10/2010US20100144640 Molecules designated b7l-1
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144633 Chloroplast expression of membrane proteins
06/10/2010US20100144628 Hepatopoietin and use thereof
06/10/2010US20100144619 Antimicrobial Protein Specific to Staphylococcus Aureus
06/10/2010US20100144600 Osteoprotegerin variant proteins
06/10/2010US20100144589 Methods of predicting cancer lethality using replikin counts
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010US20100144552 siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
06/10/2010US20100144551 Cytokine production regulator gene and use thereof
06/10/2010US20100144546 Genetic selection for protein folding and solubility in the bacterial periplasm
06/10/2010US20100144544 Fluorescence labelling
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/10/2010US20100144041 for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes; polynucleotide encoding an isolated non-conventional yeast arabinose transporter; biofuels
06/10/2010US20100144029 Facilitating Protein Solubility by Use of Peptide Extensions
06/10/2010US20100144026 siRNA-mediated gene silencing with viral vectors
06/10/2010US20100143989 Production Of 3-Hydroxycarboxylic Acid Using Nitrilase Mutants
06/10/2010US20100143979 Polypeptides having dna polymerase activity
06/10/2010US20100143973 Interleukin-11 Fusion Proteins
06/10/2010US20100143971 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010US20100143970 Transglutaminase having disulfide bond introduced therein
06/10/2010US20100143968 Penicillin-g acylases
06/10/2010US20100143940 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics
06/10/2010US20100143936 Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof
06/10/2010US20100143923 Detection of methicillin-resistant staphylococcus aureus
06/10/2010US20100143921 Polymorphisms in Genes Affecting Dopamine Transporter Disorders and Uses Thereof
06/10/2010US20100143920 Surfactant Protein D is a Biomarker for Steroid Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease
06/10/2010US20100143918 Translocation and mutant ros kinase in human non-small cell lung carcinoma
06/10/2010US20100143902 Methods and nucleic acids for analyses of cellular proliferative disorders
06/10/2010US20100143896 Sequence capable of enhancing the expression of gene under moderately low temperature
06/10/2010US20100143894 Quantitative Detection of Hdv by Real-Time Rt-Pcr
06/10/2010US20100143886 In vivo hcv resistance to anti-viral inhibitors
06/10/2010US20100143885 Detection of human papillomavirus
06/10/2010US20100143881 Selective detection of human rhinovirus
06/10/2010US20100143536 Compositions and methods for reducing h2s levels in fermented beverages
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143450 DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA
06/10/2010US20100143442 Growth factor complexes and modulation of cell migration and growth
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143411 Method for identification of t-lymphocyte antigens
06/10/2010US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
06/10/2010US20100143400 Immunostimulatory Oligonucleotides
06/10/2010US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143379 Mif agonists and antagonist and therapeutic uses thereof
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143367 Novel anti-cd98 antibody
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143349 Humanized anti-rage antibody
06/10/2010US20100143330 Methods of treating disorders associated with fat storage
06/10/2010US20100143323 Modified phosphatases
06/10/2010US20100143315 Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof
06/10/2010US20100143302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
06/10/2010US20100143292 Il-21 variants
06/10/2010US20100143288 Human granulocyte-colony stimulating factor isoforms
06/10/2010US20100140110 Microfluidic-based lab-on-a-test card for a point-of-care analyzer
06/10/2010US20100140086 Methods and apparatus for improved luminescence assays using microparticles
06/10/2010CA2745832A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/10/2010CA2745746A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
06/10/2010CA2744987A1 Method for the synthesis of phosphorus atom modified nucleic acids
06/09/2010EP2194147A1 Multiplex amplification of polynucleotides
06/09/2010EP2194145A1 Diagnosing and monitoring transplant rejection based on marker expression levels
06/09/2010EP2194129A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
06/09/2010EP2194128A1 Compositions and methods for inhibiting expression of the PCSK9 gene
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 899